CD38 and rheumatoid arthritis: In this study, MR analysis indicated that a GFD may protect against RA, with CD14+ CD16+ monocyte absolute count, CD14+ CD16+ monocyte %monocyte, and CD20 on IgD+ CD38^dim B cells identified as potential mediating factors.